2024 | Efficacy of genotype-matched vaccine against re-emerging genotype V Japanese encephalitis virus | EMERGING MICROBES & INFECTIONS |
2024 | A vaccine platform targeting lung-resident memory CD4+ T-cells provides protection against heterosubtypic influenza infections in mice and ferrets
| NATURE COMMUNICATIONS |
2024 | Antiviral activity of the water extract and ethanol extract of Sorbus commixta against influenza A virus in vitro
| HELIYON |
2024 | Egg microneedles for transdermal vaccination of inactivated influenza virus | BIOMATERIALS SCIENCE |
2024 | Harnessing Pentameric Scaffold of Cholera Toxin B (CTB) for Design of Subvirion Recombinant Dengue Virus Vaccine
| VACCINES |
2024 | Comparative Evaluation of Recombinant and Acellular Pertussis Vaccines in a Murine Model
| VACCINES |
2023 | Highly chromophoric dual-terminus labeling of an intrinsically disordered native eukaryotic protein of interest at nanoscale | INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES |
2023 | AB5-Type Toxin as a Pentameric Scaffold in Recombinant Vaccines against the Japanese Encephalitis Virus
| TOXINS |
2023 | What are the considerations when selecting a model for influenza drug discovery? | EXPERT OPINION ON DRUG DISCOVERY |
2022 | Thermostable H1 hemagglutinin stem with M2e epitopes provides broad cross-protection against group1 and 2 influenza A viruses
| MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT |
2022 | Impact of hemagglutination activity and M2e immunity on conferring protection against influenza viruses | VIROLOGY |
2022 | A chimeric thermostable M2e and H3 stalk-based universal influenza A virus vaccine
| NPJ VACCINES |
2022 | Prospects on Repurposing a Live Attenuated Vaccine for the Control of Unrelated Infections
| FRONTIERS IN IMMUNOLOGY |
2022 | Enhanced cross protection by hetero prime-boost vaccination with recombinant influenza viruses containing chimeric hemagglutinin-M2e epitopes
| VIROLOGY |
2022 | Comparison of the effects of different potent adjuvants on enhancing the immunogenicity and cross-protection by influenza virus vaccination in young and aged mice
| ANTIVIRAL RESEARCH |
2021 | RNA-assisted self-assembly of monomeric antigens into virus-like particles as a recombinant vaccine platform | BIOMATERIALS |
2021 | A Host-Restricted Self-Attenuated Influenza Virus Provides Broad Pan-Influenza A Protection in a Mouse Model
| FRONTIERS IN IMMUNOLOGY |
2021 | Epigallocatechin-3-Gallate as a Novel Vaccine Adjuvant
| FRONTIERS IN IMMUNOLOGY |
2021 | RNA-dependent assembly of chimeric antigen nanoparticles as an efficient H5N1 pre-pandemic vaccine platform
| NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE |